Research and Markets


Printer Friendly

Printed from http://www.researchandmarkets.com/reports/1197442


Benchmarking the Pharmaceutical Market by Drug Delivery to 2014


Description: Drug delivery can play an important role at all stages of a drug's lifecycle and has become an ever present feature in the business model of the leading pharmaceutical companies. Using the PharmaVitae Explorer database, the report provides an in depth sales analysis of the specific routes of administration driving the pharmaceutical market out to 2014

Scope


- Assess how drug delivery has become an ever present feature in the business model of the leading pharmaceutical companies

- Provides an insight into the prominent technology types in the expansive drug delivery segment

- Benchmarks the sales performance of the leading prescription pharmaceutical companies in terms of drug delivery


Highlights of this title

The oral and injectable segments are the dominant routes of administration in the prescription pharmaceutical market, accounting for more than 80% of combined sales in 2008.

Injectables will see the biggest increase in annual sales at $49 billion over 200814. In contrast, oral drugs will collectively decline by $10.9 billion over the same period.

Slow-growth therapy areas are generally entrenched in oral medications. This dynamic is mirrored by the fast-growth therapy areas, where novel injectable drugs will primarily drive growth.

Key reasons to purchase this title


- Assess the ways in which drug delivery technology to add value to pharmaceutical products

- Determine current R&D trends in the drug delivery segment

- Examine the long-term sales performance of each delivery type across the leading prescription pharmaceutical players


Contents: ABOUT DATAMONITOR HEALTHCARE
About the PharmaVitae team

Chapter 1 About this report
PharmaVitae Explorer database

Chapter structure
Data sourcing

Chapter 2 Executive summary
Key findings
Drug delivery overview
Prescription pharmaceutical market by delivery mechanism, 2002-14

Chapter 3 Overview of drug delivery market
Key findings
Introduction to drug delivery

Chapter 4 Segmentation of the drug delivery market
Key findings
Segmentation of the drug delivery market
Segmentation by mode of delivery
Segmentation by technology type
Merging technology with commercial opportunity

Chapter 5 Sales analysis of the pharmaceutical market by drug delivery
Key findings
A delivery-focused sales analysis of the leading prescription pharmaceutical companies
Prescription pharmaceutical market by delivery mechanism
Drug delivery analysis of the leading pharmaceutical players by company
Drug delivery analysis of the leading pharmaceutical players by company

Chapter 6 Appendix
References
Abbreviations
Exchange rates
About Datamonitor
Datamonitor consulting
Disclaimer

TABLE OF TABLES
Table 1: Classification system employed to dissect the delivery technology space
Table 2: The principal modes of delivery in the pharmaceutical industry
Table 3: List of companies covered by PharmaVitae
Table 4: Exchange rates, 2009


TABLE OF FIGURES
Figure 1: The PharmaVitae Explorer
Figure 2: Drug delivery systems can improve the therapeutic and commercial performance of a pharmaceutical product
Figure 3: A selection of pharmaceutical players operating within the drug delivery space
Figure 4: Segmentation of the drug delivery space by technology type
Figure 5: Drug delivery system by mode of administration
Figure 6: Technology count vs global pharma market share by delivery mechanism
Figure 7: Prescription pharmaceutical market by delivery mechanism, sales ($m), 2002-14
Figure 8: Compound annual growth rates by delivery mechanism (%), 2008-14
Figure 9: Absolute sales growth by delivery mechanism between 2008 and 2014 ($m)
Figure 10: Therapy area forecasts segmented by delivery mechanism
Figure 11: Product lifecycle stage forecasts segmented by delivery mechanism
Figure 12: Technology type forecasts segmented by delivery mechanism
Figure 13: Top 20 companies ranked by 2008 oral sales
Figure 14: Top 20 companies ranked by 2008 injectable sales
Figure 15: Top 20 oral products ranked by 2014 sales
Figure 16: Top 20 injectable products ranked by 2014 sales
Figure 17: Drug delivery systems can improve the therapeutic and commercial performance of a pharmaceutical
Figure 18: Johnson & Johnson Risperdal franchise sales ($m), 2002-08
Figure 19: A selection of pharmaceutical players operating within the drug delivery space
Figure 20: Segmentation of drug delivery space by modality and technology
Figure 21: Segmentation of the drug delivery space by technology type
Figure 22: Drug delivery system by mode of administration
Figure 23: Technology count vs global pharma market share by delivery mechanism
Figure 24: Global pharmaceutical market by delivery mechanism
Figure 25: Prescription pharmaceutical market by delivery mechanism, sales ($m), 2002-14
Figure 26: Compound annual growth rates by delivery mechanism, 2008-14
Figure 27: Absolute sales growth by delivery mechanism between 2008 and 2014 ($m)
Figure 28: Long-term sales analysis across the delivery space
Figure 29: Therapy area forecasts segmented by delivery mechanism
Figure 30: Territory-specific forecasts segmented by delivery mechanism
Figure 31: Product lifecycle stage forecasts segmented by delivery mechanism
Figure 32: Technology type forecasts segmented by delivery mechanism
Figure 33: Age of drug forecasts segmented by delivery mechanism
Figure 34: Prescription drug sales of Big Pharma peer set by delivery mechanism
Figure 35: Prescription drug sales of Biotech peer set by delivery mechanism
Figure 36: Prescription drug sales of Generics peer set by delivery mechanism
Figure 37: Prescription drug sales of Japan peer set by delivery mechanism
Figure 38: Prescription drug sales of Mid Pharma peer set by delivery mechanism
Figure 39: Top 20 companies ranked by 2008 oral sales
Figure 40: Top 20 companies ranked by 2014 oral sales
Figure 41: Oral sales dependency versus long-term growth of the top 20 oral drug companies
Figure 42: Top 20 companies ranked by 2008 injectable sales
Figure 43: Top 20 companies ranked by 2014 injectable sales
Figure 44: Injectable sales dependency versus long-term growth of the top 20 injectables drug companies
Figure 45: Injectable sales dependency versus long-term growth of the top 20 injectables drug companies, biologic focus 2014 (%)
Figure 46: Top 20 oral products ranked by 2008 sales
Figure 47: Top 20 oral products ranked by 2014 sales
Figure 48: Oral growth drivers/resistors, 2008-14
Figure 49: Top 20 injectable products ranked by 2008 sales
Figure 50: Top 20 injectable products ranked by 2014 sales
Figure 51: Injectable growth drivers/resistors, 2008-14





Ordering: Order Online - visit http://www.researchandmarkets.com/reports/1197442

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


Research and Markets Page 1 of 2
Printed 13/02/2012 01:36:54
Fax Order Form
To place an order via fax simply print this form, fill in the information below and fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net

Order information
Please verify that the product information is correct and select the format you require.
Product Name:
Benchmarking the Pharmaceutical Market by Drug Delivery to 2014
Web Address:
http://www.researchandmarkets.com/reports/1197442
Office Code:
OC8IHINLSNNSS

Report formats
Please enter the quantity of the report format you require.

Format Quantity Price
Hard Copy €5,885.00 + EUR€ 50.00 Shipping/Handling *
Electronic (PDF) - Single User €5,809.00
Electronic (PDF) - Enterprisewide €14,521.00
* Shipping/Handling is only charged once per order.


Contact information
Please enter all the information below in BLOCK CAPITALS.

First Name:   Last Name:  
Email Address:
Job Title:
Organisation:
Address:
City:
Postal/Zip Code:
Country:
Phone Number:
Fax Number:


Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
Research and Markets Page 2 of 2
Printed 13/02/2012 01:36:54

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

 Pay by Credit Card:
American Express
Diners Club
Master Card
Visa
Cardholder's Name:
Cardholder's Signature:
Expiry Date: /
Card Number:
CVV Security Code:
Issue Date: /   (Diners Club only)


 Pay by Check:
Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.


 Pay by Wire Transfer:
Please transfer funds to:

Account number: 83313083
Sort code: 98-53-30
Swift code: ULSBIE2D
IBAN number: IE78ULSB98533083313083
Bank Address: Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland.
If you have a Marketing Code please enter it below:
Marketing Code:


Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)